Hospital Universitario de Guadalajara-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3

    Histology and histopathology, Vol. 39, Núm. 1, pp. 35-40

  2. Elevated tissue expression of RANKL and RANK is associated with poorer survival rates in pancreatic cancer patients

    Histology and histopathology, Vol. 39, Núm. 9, pp. 1133-1140

  3. Exacerbated Activation of the NLRP3 Inflammasome in the Placentas from Women Who Developed Chronic Venous Disease during Pregnancy

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

  4. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

    Medicina (Lithuania), Vol. 60, Núm. 1

  5. Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer

    Current Issues in Molecular Biology, Vol. 46, Núm. 5, pp. 3839-3865

2023

  1. An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  2. Clinical and Translational Applications of Serological and Histopathological Biomarkers in Metastatic Breast Cancer: A Comprehensive Review

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  3. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review)

    Oncology reports, Vol. 50, Núm. 6

  4. Placentas from Women with Late-Onset Preeclampsia Exhibit Increased Expression of the NLRP3 Inflammasome Machinery

    Biomolecules, Vol. 13, Núm. 11

  5. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

    Journal of Personalized Medicine, Vol. 13, Núm. 2

2022

  1. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer

    Cancers, Vol. 14, Núm. 8

  2. Clinical and Novel Biomarkers in Penile Carcinoma: A Prospective Review

    Journal of Personalized Medicine, Vol. 12, Núm. 9

  3. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

  4. Modification of the Polymer of a Bone Cement with Biodegradable Microspheres of PLGA and Loading with Daptomycin and Vancomycin Improve the Response to Bone Tissue Infection

    Polymers, Vol. 14, Núm. 5

  5. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer

    Antioxidants, Vol. 11, Núm. 4

  6. Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma—A Histopathological Study

    Medicina (Lithuania), Vol. 58, Núm. 6

  7. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

  8. Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  9. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine

    Frontiers in Oncology, Vol. 12

2021

  1. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)

    Oncology Letters, Vol. 22, Núm. 5